Hanson Wade have taken the decision to cancel this meeting. Please do accept our apologies for any inconvenience or disappointment this will cause. Please register your interest here if you would like updates on the meeting or topic.

Deploy Advanced Models to Enhance Your Confidence & Understanding of Molecular Biological Pathway & Efficacy

Developing a novel therapeutic candidate for autoimmune diseases is a complex challenge. Currently, traditional preclinical models do not provide the accuracy to understand the mechanisms of action and lack translational specificity for clinical approval. Over the last few years, we have seen breakthroughs in more advanced model utilization to validate novel target and biologic pathways, enabling faster preclinical-clinical drug development.

The PREDiCT: Autoimmune Disease Modeling Summit will arrive in San Francisco to showcase the latest therapeutic targets to deepen understanding of disease pathogenesis and improve drug development.

Join us as we bring together 60+ experts across the autoimmune industry to understand the unique drivers of disease symptomology.

Apply the latest case study evidence from novel therapeutic targets to increase your preclinical model validity and candidate success. With the latest case studies from Autoimmune Centers for Excellence, Immunic AG, Allergan, Cue Biopharma, the 3-day summit will provide you with validated mechanisms to improve your preclinical and clinical outcomes and accelerate your autoimmune pipeline.

Download the Full Event Guide here.

 

Expert Confirmed Speakers Include:

Anish Suri

Chief Scientific Officer

Cue Biopharma

Changyun Hu

Senior Scientist

Jounce Therapeutics

David Fox

Professor of Rheumatology and Professor of Internal Medicine

University of Michigan

Hella Kohlhof

Chief Scientific Officer

Immunic AG

Jason DeVoss

Principal Scientist

Amgen Inc.

Michael Mingueneau

Associate Director & Senior Scientist

Biogen Idec

Roland Grenningloh

Senior Director - Immunology Neurology

EMD Serono

Sunhwa Kim

Principal Scientist

Merck & Co

Our 2020 Partners

Program Partner:

download